The genetic basis of human keratinocyte immortalisation in squamous cell carcinoma development: The role of telomerase reactivation

European Journal of Cancer Part A

Volumn 33, Issue 5, 1997, Pages 727-734

  Parkinson, E K ^a   Newbold, R F ^b   Keith, W N ^c  

^a BEATSON INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

^b BRUNEL UNIVERSITY   (United Kingdom)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

CDKN2; immortality; senescence; squamous cell carcinoma; telomerase

Indexed keywords

TELOMERASE;

ARTICLE; CELL AGING; CELL IMMORTALIZATION; CHROMOSOME 3Q; ENZYME REACTIVATION; GENE EXPRESSION REGULATION; GENE LOCATION; HUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; SKIN CARCINOGENESIS; SQUAMOUS CELL CARCINOMA; TELOMERE; TUMOR SUPPRESSOR GENE;

CARCINOMA, SQUAMOUS CELL; CELL AGING; CELL DIVISION; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 3; ENZYME ACTIVATION; ENZYME REACTIVATORS; GENE EXPRESSION; GENES, TUMOR SUPPRESSOR; HUMANS; KERATINOCYTES; TELOMERASE;

EID: 0031010341     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(97)00063-4     Document Type: Article

References (81)

1. Hayflick L. The limited in vitro lifetime of human diploid cell strains. Exp Cell Res 1965, 37, 614-636.
2. Rheinwald JG, Green H. Serial cultivation of strains of human epidermal keratinocytes: the formation of keratinizing colonies from single cells. Cell 1975, 6, 331-343.
3. Wille JJ Jr, Pittelkow MR, Shipley GD, Scott RE. Integrated control of growth and differentiation of normal human prokera-tinocytes cultured in serum-free medium: clonal analyses, growth kinetics, and cell cycle studies. J Cell Physiol 1984, 121, 31-44.
4. Barrandon Y, Green H. Three clonal types of keratinocyte with different capacities for multiplication. Proc Natl Acad Sci USA 1987, 84, 2302-2306.
5. Dimri GP, Lee X, Basile G, et al. A biomarker that identifies senescent human cells in culture and in ageing skin in vivo. Proc Natl Acad Sci USA 1995, 92, 9863-9867.
6. Edington KG, Loughran OP, Berry JJ, Parkinson EK. Cellular immortality: a late event in the progression of human squamous cell carcinoma of the head and neck associated with p53 alteration and a high frequency of allele loss. Mol Carcinogenesis 1995, 13, 254-265.
7. Watson JD. Origin of concatameric T7 DNA. Nature New Biol 1972, 239, 197-201.
8. Greider CW, Blackburn EH. Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell 1995, 81, 405-413.
9. Wright WE, Piatyszek MA, Rainey WE, Byrd JW, Shay JW. Telomerase activity in human germline and embryonic tissues and cells. Dev Genet 1996, 18, 173-179.
10. Harley CB, Futcher GB, Greider CW. Telomeres shorten during ageing of human fibroblasts. Nature 1990, 345, 458-460.
11. de Lange T. Activation of telomerase in a human tumor. Proc Natl Acad Sci USA 1994, 91, 2882-2885.
12. Vaziri H, Dragowska W, Allsopp RC, Thomas TE, Harley CB, Lansdorp PM. Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age. Proc Natl Acad Sci USA 1994, 91, 9857-9860.
13. Wainwright LJ, Middleton PG, Rees JL. Changes in mean telomere length in basal cell carcinomas of the skin. Genes Chromosomes Cancer 1995, 12, 45-49.
14. Hastie ND, Dempster M, Dunlop MG, Thompson AM, Green DK, Allshire RC. Telomere reduction in human colorectal carcinoma and with ageing. Nature 1990, 346, 866-868.
15. Wright WE, Brasiskyte D, Piatyszek MA, Shay JW. Experimental elongation of telomeres extends the lifespan of immortal x normal cell hybrids. EMBO J 1996, 15, 1734-1741.
16. Harle-Bachor C, Boukamp P. Telomerase activity in the regenerative basal layer of the epidermis in human skin and in immortal and carcinoma-derived skin keratinocytes. Proc Natl Acad Sci USA 1996, 93, 6476-6481.
17. Yasumoto S, Kunimara C, Kikuchi K, et al. Telomerase activity in normal human epithelial cells. Oncogene 1996, 13, 433-439.
18. Jones PH, Watt FM. Stem cell patterning and fate in human epidermis. Cell 1995, 80, 83-93.
19. Holt SE, Shay JW, Wright WE. Refining the telomere-telomerase hypothesis of ageing and cancer. Nature Biotech 1996, 14, 836-839.
20. von Zglinicki T, Saretzki G, Docke W, Lotze C. Mild hyperoxia shortens telomeres and inhibits proliferation of fibroblasts: a model for senescence? Exp Cell Res 1995, 220, 186-193.
21. Orr WC, Sohal RS. Extension of life-span by overexpression of superoxide dismutase and catalase in Drosophila melanogaster. Science 1994, 263, 1128-1130.
22. Lithgow GJ, White TM, Melov S, Johnson TE. Thermotolerance and extended lifespan conferred by single gene mutations and induced by thermal stress. Proc Natl Acad Sci USA 1995, 92, 7540-7544.
23. Saito H, Hammond AT, Moses RE. The effect of low oxygen tension on the in vitro replicative life span of human diploid fibroblast cells and their transformed derivatives. Exp Cell Res 1995, 217, 272-279.
24. Davidson JF, Whyte B, Bissinger PH, Schiestl RH. Oxidative stress is involved in heat-induced cell death in Saccharomyces cerevisiae. Proc Natl Acad Sci USA 1996, 93, 5116-5121.
25. Thompson KVA, Holliday R. Effect of temperature on the longevity of human fibroblasts in culture. Exp Cell Res 1973, 80, 354-360.
26. Shiloh Y. Ataxia-telangiectasia: closer to unravelling the mystery. Eur J Hum Genet 1995, 3, 116-138.
27. Metcalf JA, Parkhill J, Campbell L, et al. Accelerated telomeric shortening in ataxia telangiectasia. Nature Genet 1996, 13, 350-353.
28. Greenwell PW, Kronmal SL, Porter SE, Gassenhuber J, Obermaier B, Petes TD. TELl, a gene involved in controlling telomere length in S. cerevisiae, is homologous to the human ataxia telangiectasia gene. Cell 1995, 82, 823-829.
29. Vaziri H, Schacter F, Uchida I, et al. Loss of telomeric DNA during ageing of normal and trisomy 21 human lymphocytes. Am J Hum Genet 1993, 52, 661-667.
30. Cossarizza A, Ortolani C, Forti E, et al. Age-related expansion of functionally inefficient cells with markers of natural killer activity in Down's syndrome. Blood 1991, 77, 1263-1270.
31. Ceballos-Picot I, Nicole A, Sinet PM. Cellular clones and transgenic mice overexpressing copper - zinc superoxide dismutase: models for the study of free radical metabolism and ageing. EXS 1992, 62, 89-98.
32. Yu CE, Oshima J, Fu Y-H, et al. Positional cloning of the Werner's syndrome gene. Science 1996, 272, 258-262.
33. Kruk PA, Rampino NJ, Bohr VA. DNA damage and repair in telomeres: relation to ageing. Proc Natl Acad Sci USA 1995, 92, 258-262.
34. Smith JR, Whitney RG. Intraclonal variation in proliferation potential of human diploid fibroblasts: stochastic mechanism for cellular ageing. Science 1980, 207, 82-84.
35. Sandell LL, Zakian VA. Loss of yeast telomere: arrest, recovery, and chromosome loss. Cell 1993, 75, 729-739.
36. Stein GL, Dulic V. Origins of G1 arrest in senescent human fibroblasts. Bioessays 1995, 17, 537-543.
37. Maity A, McKenna WG, Muschel RJ. The molecular basis for cell cycle delays following ionizing radiation: a review. Radit Oncol 1994, 31, 1-13.
38. Atadja P, Wong H, Garkavtsev I, Veilette C, Riabowol K. Increased activity of p53 in senescing fibroblasts. Proc Natl Acad Sci USA 1995, 92, 8348-8352.
39. Noda A, Ning Y, Venable SF, Pereira-Smith OM, Smith JR. Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp Cell Res 1994, 211, 90-98.
40. Dulic V, Drullinger LF, Lees E, Reed SI, Stein GH. Altered regulation of G1 cyclins in senescent human diploid fibroblasts: accumulation of inactive cyclin E-Cdk2 and cyclin Dl-Cdk2 complexes. Proc Natl Acad Sci USA 1993, 90, 11034-11038.
41. Stein GH, Beeson M, Gordon L. Failure to phosphorylate the retinoblastoma gene product in senescent human fibroblasts. Science 1990, 249, 666-669.
42. Cristofalo V, Sharf BB. Cellular senescence and DNA synthesis: thymidine incorporation as a measure of population age in human diploid cells. Exp Cell Res 1973, 76, 419-427.
43. Hara E, Smith R, Parry D, Tahara H, Stone S, Peters G. Regulation of p16CDKN2 expression and its implications for cell immortalization and senescence. Mol Cell Biol 1996, 16, 859-867.
44. INK4A with human keratinocyte replicative senescence: relationship of dysfunction to immortality and neoplasia. Oncogene 1996, 13, 561-567.
45. Koh J, Enders GH, Dynlacht BD, Harlow E. Tumour-derived p16 alleles encoding proteins defective in cell cycle inhibition. Nature 1995, 375, 506-510.
46. Reznikoff CA, Yeager TR, Belair CD, Savelieva E, Puthenveettil JA, Stadler WM. Elevated p16 at senescence and loss of p16 at immortalization in human papillomavirus 16 E6, but not E7, transformed human uroepithelial cells. Cancer Res 1996, 56, 2886-2890.
47. Kennedy BK, Austriaco NR, Zhang J, Guarante L. Mutation in the silencing gene SIR4 can delay ageing in S. cerevisiae. Cell 1995, 80, 485-496.
48. Marcand S, Buck SW, Moretti P, Gilson E, Shore D. Silencing of genes at nontelomeric sites in yeast is controlled by sequestration of silencing factors at telomeres by RAP 1 protein. Genes Dev 1996, 10, 1297-1309.
49. Seshradi T, Campisi J. Repression of c-fos transcription and an altered genetic program in senescent human fibroblasts. Science 1990, 247, 205-209.
50. Hara E, Tsuri H, Shinozaki A, Nakada S, Oda K. Cooperative effect of antisense-Rb and antisense-p53 oligomers on the extension of lifespan in human diploid fibroblasts, TIG-1. Biochem Biophys Res Comm 1991, 179, 528-534.
51. Shay JW, Pereira-Smith OM, Wright WE. A role for both RB and p53 regulation of human cellular senescence. Exp Cell Res 1991, 196, 33-40.
52. Counter CM, Avilion AA, LeFeuvre CE, et al. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J 1992, 11, 1921-1929.
53. Wright WE, Pereira-Smith OM, Shay JW. Reversible cellular sensecence: implications for immortalization of normal human diploid fibroblasts. Mol Cell Biol 1989, 9, 3088-3092.
54. Radna RL, Caton Y, Jha KK, et al. Growth of immortal Simian virus 40 tsA-transformed fibroblasts is temperature dependent. Mol Cell Biol 1989, 9, 3093-3096.
55. Rheinwald JG, Beckett MA. Tumorigenic keratinocyte lines requiring anchorage and fibroblast support cultured from human squamous cell carcinomas. Cancer Res 1981, 41, 1657-1663.
56. Shay JW, Wright WE. The reactivation of telomerase activity in cancer progression. Trends Genet 1996, 12, 129-131.
57. Yin Y, Tainsky MA, Bischoff FZ, Strong LC, Wahl GM. Wild type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles. Cell 1992, 70, 937-948.
58. Wiesmuller L, Cammenga J, Deppert WW. In vivo assay of p53 function in homologous recombination between simian virus 40 chromosomes. J Virol 1996, 70, 737-744.
59. Carder P, Wyllie AH, Purdie CA, et al. Stabilised p53 facilitates aneuploid clonal divergence in colorectal cancer. Oncogene 1993, 8, 1397-1401.
60. Wynford-Thomas D, Bond JA, Wyllie FS, Jones CJ. Does telomere shortening drive selection for p53 mutation in human cancer? Mol Carcinogenesis 1995, 12, 119-123.
61. Shay JW, Wright WE, Werbin H. Loss of telomeric DNA during ageing may predispose cells to cancer. Int J Oncol 1993, 3, 559-563.
62. Loughran O, Edington KG, Berry IJ, Clarke LJ, Parkinson EK. Loss of heterozygosity of chromosome 9p21 is associated with the immortal phenotype of neoplastic human head and neck keratinocytes. Cancer Res 1994, 54, 5045-5049.
63. Cairns P, Ploascik TJ, Eby Y. Frequency of homozygous deletion at p16/cdkn2 in primary human tumors. Nature Genet 1995, 11, 210-212.
64. Merlo A, Herman JG, Mao J, et al. 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/cdkn2/mts1 in human cancers. Nat Med 1995, 1, 686-692.
65. Reed AL, Califano J, Cairns P, et al. High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma. Cancer Res 1996, 56, 3630-3633.
66. Pereira-Smith OM, Smith JR. Genetic analysis of indefinite division in human cells: identification of four complementation groups. Proc Natl Acad Sci USA 1988, 85, 6042-6046.
67. Ning Y, Weber JL, Killary AM, Ledbetter DH, Smith JR, Pereira-Smith OM. Genetic analysis of indefinite division in human cells: evidence for a cell senescence-related gene(s) on human chromosome 4. Proc Natl Acad Sci USA 1991, 88, 5635-5639.
68. Hensler PJ, Annab LA, Barrett JC, Pereira-Smith OM. A gene involved in control of cellular senescence on human chromosomes 1q. Mol Cell Biol 1994, 14, 2291-2297.
69. Ogata T, Auysawa D, Namba M, Takahashi E, Oshimura M, Oishi M. Chromosome 7 suppresses indefinite division of nontumorigenic immortalized human fibroblast cell lines KMST-6 and SUSM-1. Mol Cell Biol 1993, 13, 6036-6043.
70. Loughran O, Clark LJ, Bond J, et al. Evidence for the inactivation of multiple replicative lifespan genes in immortal human squamous cell carcinoma keratinocytes. Oncogene, in press.
71. Kim NW, Piatyszak MA, Prowse KR, et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994, 266, 2011-2014.
72. Feng J, Funk WD, Wang S-S, et al. The RNA component of human telomerase. Science 1995, 269, 1236-1241.
73. Hiyama E, Hiyama K, Yokoyama T, Matsuura Y, Piatyszek MA, Shay JW. Correlating telomerase activity levels with human neuroblastoma outcomes. Nat Med 1995, 1, 249-255.
74. Greaves M. Is telomerase activity in cancer due to selection of stem cells and differentiation arrest? Trends Genet 1996, 12, 127-128.
75. Taylor RS, Ramirez RD, Ogoshi M, Chaffins M, Piatyszek MA, Shay JW. Detection of telomerase activity in malignant and non malignant skin conditions. J Invest Dermatol 1996, 106, 759-765.
76. Hiyama K, Hiyama E, Ishoika S. Telomerase activity in small-cell and non-small-cell lung cancers. J Natl Cancer Inst 1995, 87, 895-902.
77. Ohmura H, Tahara H, Suzuki M. Restoration of the cellular senescence program and repression of telomerase by chromosome 3. Jpn J Cancer Res 1995, 86, 899-904.
78. Speicher MR, Howe C, Crotty P, Du Manoir S, Costa J, Ward DC. Comparative genomic hybridization detects novel deletions and amplifications in head and neck squamous cell carcinomas. Cancer Res 1995, 55, 1010-1013.
79. Hermsen MAJA, Joenje H, Arwert F, et al. Centromeric breakage as a major cause of cytogenetic abnormalities in oral squamous cell carcinoma. Genes Chromosomes Cancer 1996, 15, 1-9.
80. Soder AI, Hoare SF, Muire S, Going JJ, Parkinson EK, Keith WN. Amplification and increased gene dosage of the telomerase RNA gene in human cancer. Oncogene, in press.
81. Avilion AA, Piatyszek MA, Gupta J, Shay JW, Bacchetti S, Greider CW. Human telomerase RNA and telomerase activity in immortal cell lines and tumor tissues. Cancer Res 1996, 56, 645-650.